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Introduction {#sec001}
============

Sleep plays an essential role in the health and well-being throughout one's life. Getting enough good quality sleep is necessary for physiologic restoration and recovery, and the lack of it has been identified as a growing public health concern. Just as adverse sleep issues can increase the risk of health problems, several diseases and disorders can also affect the amount and quality of sleep in individuals. In perhaps the earliest study that looked at the relationship between sleep and health, Hammond \[[@pone.0235816.ref001]\] observed those who had 7 hours of sleep to report the lowest mortality during a 2-year follow up, with increased death rates found among those who reported shorter or longer sleep duration \[[@pone.0235816.ref001]\]. The results from this study appear to have driven subsequent research on sleep duration and physical health. For example, several cohort studies have focused on the relationship between sleep duration with cardiovascular- and cancer- specific outcomes and all-cause mortality \[[@pone.0235816.ref002]--[@pone.0235816.ref005]\]. Research on sleep quality only began to gain more attention after Ford and Kamerow \[[@pone.0235816.ref006]\] found insomnia to greatly increase the risk of psychiatric disorders. The conceptualization of sleep as two distinct constructs of duration and quality has since been recognised and despite having some extent of overlap, there are qualitative differences between them. "Sleep duration" refers to the total amount of sleep obtained, either during the nocturnal sleep episode or across the 24-h period \[[@pone.0235816.ref007]\] while "sleep quality" includes the quantitative aspects of sleep such as sleep quantity, sleep latency, or number of arousals at night, as well as the largely subjective indices of sleep, such as depth of sleep, how well rested one feels upon awakening and general satisfaction with sleep \[[@pone.0235816.ref008]\].

While many studies have since examined the link between sleep and chronic diseases, Bin \[[@pone.0235816.ref009]\] identified several limitations in this field of research. Firstly, it has been proposed by Bin that much of these evidence points to connecting sleep duration to physical health, and linking sleep quality to mental health. While several meta-analyses have found significant associations between insomnia and mortality and cardiovascular diseases \[[@pone.0235816.ref010]--[@pone.0235816.ref012]\], there remains a dearth of research looking at the relationship between sleep disturbance and other physical diseases, or that between sleep duration and psychiatric diseases. Secondly, Bin also highlighted that sleep duration and quality have been conceptualized so distinctly that many have failed to recognise that they are measures of the same underlying phenomenon \[[@pone.0235816.ref009]\]. As a result, nationally representative data on both sleep quality and sleep duration are rarely available from the same source. While few studies conducted in large population samples may have examined the individual association of the two sleep measures with both physical and mental health \[[@pone.0235816.ref013]--[@pone.0235816.ref017]\], mental health was mainly evaluated only at symptomatic level such as the use of emotional functioning, perceived stress, and severity of depression and anxiety measured on screening instruments.

As noted previously, sleep characteristics in general populations have been studied; typically by assessing sleep duration and quality as the outcomes \[[@pone.0235816.ref018]--[@pone.0235816.ref021]\]. Based on recommendations by the National Sleep Foundation, the age-appropriate sleep duration was suggested to be 7 to 9 hours for an healthy younger adult or adult with normal sleep, and 7 to 8 hours of sleep for an older adult \[[@pone.0235816.ref022]\]. Perceived good sleep quality, on the other hand, is characterized by subjective reports of the continuity and restfulness of sleep, including absence of significant sleep disturbances. The roles of sleep duration and sleep quality are believed to be inextricably linked; people with short and long sleep tend to be those who also report sleep disturbance \[[@pone.0235816.ref023], [@pone.0235816.ref024]\]. In other words, the short and long sleep durations may reflect poor sleep quality beyond absolute sleep hours. Yet, other evidence also suggested that sleep quality may not be synonymous with sleep duration. It has been found that the reported usual sleep durations among groups who complain of insomnia and sleeping pill use were well within the range of those without sleep problems \[[@pone.0235816.ref025]\], while individuals with poor sleep quality were also found to have sufficient sleep \[[@pone.0235816.ref026]\]. For this reason, it may be more appropriate for studies that include sleep duration or sleep quality as the variable of interest to adjust for the effect of each other in respective analysis.

To address the above limitations and to elucidate the relationship between sleep and chronic diseases, this study therefore aimed to examine the associations of sleep duration and sleep quality (independently and combined) with lifetime or 12-month physical and mental health diagnoses, using data from a national, epidemiological survey.

Materials and methods {#sec002}
=====================

Study overview {#sec003}
--------------

Data was collected as part of the Singapore Mental Health Study (SMHS) 2016, the second epidemiological survey conducted to establish the prevalence of specific mental illnesses and their associated factors among adult residents (citizen and permanent residents) aged ≥18 years in Singapore \[[@pone.0235816.ref027]\]. Approval of study was obtained from the institutional review board- National Healthcare Group, Domain Specific Review Board, Singapore. Field interviewers were required to undergo a two-week structured training program conducted by the research team members from the Institute of Mental Health, Singapore, who had been trained and certified by the official World Mental Health Composite International Diagnostic Interview (WMH-CIDI) Training and Research Centre at the University of Michigan. Those who did not meet the standard of knowledge and competency were not allowed to proceed with the fieldwork, which was held between the period of August 2016 to April 2018. Computer-assisted personal interviews (CAPIs) were conducted face-to-face by the interviewers in any of the three preferred languages: English, Chinese and Malay.

Sample {#sec004}
------

The survey was designed to be representative of adult citizens including Singaporeans and Permanent Residents aged 18 years and above. The respondents were randomly selected from a national population registry that maintains the names and sociodemographic information of all Singapore residents with 16 strata defined accordingly to ethnicity (Chinese, Malay, Indian, Others) and age groups (18--34, 35--49, 50--64, 65 and above). To ensure an adequate sample in the minority groups and improve the precision for subgroup analysis, a disproportionate stratified sampling (by age and ethnicity) was adopted; where those aged 65 years and above, Malays and Indians were oversampled. Those residents who were incapable of doing an interview due to severe physical or mental conditions, language barriers, living outside the country, institutionalized or hospitalized at the time of the survey, and those were not contactable due to incomplete or incorrect address, were determined as ineligibles and were excluded from the survey. All study participants and the legal representatives for those aged below 21 years of age provided written informed consent prior to the study. The detailed methodology of the SMHS has been described elsewhere \[[@pone.0235816.ref028]\].

Data collection {#sec005}
---------------

Information such as age, gender, ethnicity, marital status, education, employment status, household income was collected using a structured questionnaire. The height and weight of each respondent were measured to calculate their body mass index (BMI) for risk assessment of cardiovascular disease. Participants were also asked of their current smoking status (smoker, ex-smoker or non-smoker) and how often did they usually have any kind of alcoholic drink during the past 12 months. These sociodemographic and lifestyle data were treated as the main covariates.

Sleep measures {#sec006}
--------------

Although sleep quality is a widely accepted clinical construct, it represents a complex phenomenon that is not readily defined and difficult to measure objectively. To better quantify quality of sleep, the Pittsburg Sleep Quality Index (PSQI), a reliable and validated standardized measure has been developed to assess sleep quality and disturbance over the 'past month' \[[@pone.0235816.ref029]\]. This 19-item self-reported questionnaire generates seven component scores: subjective sleep quality, latency, duration, habitual sleep efficiency, sleep disturbances, use of sleep medications, and day-time dysfunction, as well as a global score that ranges from 0 to 21 and discriminates between "good" and "poor" sleepers. Although sleep duration (actual hours spent sleeping) is a component of the sleep quality, they are universally recognised as two distinct constructs. The relationships between sleep quality, and measures of health, well-being and sleepiness have been found to be independent of any effect by sleep quantity \[[@pone.0235816.ref008]\].

In the current study, we attempted to look at the independent and combined associations of sleep quality and sleep duration with various health conditions. For sleep quality, a global PSQI score of ≥5 was considered indicative of a poor sleep quality \[[@pone.0235816.ref029]\]. For sleep duration, we adopted similar categorization as previous studies \[[@pone.0235816.ref015], [@pone.0235816.ref030]\] and classified actual sleep duration into average ≤6 hours, 7--8 hours and ≥9 hours per day. The category of 7-8h/day was chosen as the reference for sleep duration to capture possible non-linear relationship between sleep duration and its associated variables, and for the purpose of comparison across studies. For the combined sleep variable (i.e., "duration + quality"), 7-8h/day & good sleep was selected as the reference category from the six available combined levels. The Cronbach's alpha for the seven components of the PSQI were 0.604, 0.701, and 0.633, respectively for the English, Chinese and Malay administered versions.

Physical disorders {#sec007}
------------------

Respondents were asked if they ever had any of the listed major health problems using a modified version of the CIDI 3.0 checklist of chronic medical disorders. The list of 18 medical disorders were (1) asthma, (2) high blood sugar or diabetes, (3) hypertension and high blood pressure, (4) arthritis or rheumatism, (5) cancer diagnosis, (6) a neurological condition, such as epilepsy, convulsions, (7) Parkinson's disease, (8) stroke or major paralysis (inability to use arms or walk), (9) congestive heart failure, (10) heart diseases including a heart attack, coronary heart diseases, angina, or other heart disease, (11) back problems including disk or spine, (12) stomach ulcer, (13) chronic inflamed bowel, enteritis, or colitis, (14) thyroid disease, (15) kidney failure, (16) migraine headaches, (17) chronic lung diseases such as chronic bronchitis or emphysema, and lastly (18) hyperlipidaemia or high cholesterol. For the purpose of this study, these 18 disorders were regrouped into 9 major categories as reported in Tables [2](#pone.0235816.t002){ref-type="table"} and [4](#pone.0235816.t004){ref-type="table"}. Any physical disorder was defined as the presence of any of the 18 chronic conditions.

Mental disorders {#sec008}
----------------

The diagnoses of mental disorders were established using the WMH-CIDI version 3.0, a fully structured diagnostic instrument based on Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) and International Classification of Disease, 10th Revision (ICD-10) Classification of Mental and Behavioural Disorders criteria. To reduce respondent burden, participants were only required to complete respective diagnostic section of the questionnaire if they had answered positively to a specific screening question. For the purpose of this study, only select mental health modules were administered to determine diagnoses of major depressive disorder (MDD), bipolar disorder (BD), dysthymic disorder (DD), general anxiety disorder (GAD), obsessive compulsive disorder (OCD) and alcohol use disorder (AUD). Any mental disorder was defined as the presence of any of the 6 mental conditions. In our study, "12-month diagnosis" is indicative of an episode within the last 12-months while "lifetime diagnosis" includes both 12-month and past episode(s) reported in the interview at that visit. Organic exclusion and diagnostic hierarchy rules were applied to generate the final diagnoses. We have examined both the lifetime and 12-month prevalence to explore possible difference in the relationship between the sleep variables and mental disorders.

Statistical analyses {#sec009}
--------------------

Data was analysed by IBM SPSS Complex Samples, version 23.0 and estimates were weighted to adjust for over-sampling and non-response. Individual weights were also post-stratified by age and ethnicity according to the Singapore residential population statistics in 2014. Descriptive statistics was tabulated for the overall sample. A series of regression models were conducted such that the estimated odds ratios (ORs) measure the strength of association between each disorder and each of the three sleep variables (sleep quality, sleep duration and "quality + duration") while controlling for other confounding variables. In these regression models (one for physical disorders, one for 12-month history of mental disorders and one for lifetime history of mental disorders), the sleep measure of interest was treated as a dependent variable while mental and physical disorders were treated as main independent variables. For example, in assessing the independent association of sleep quality with physical health, sleep quality was regressed on all the physical disorders in a single model while including sociodemographic (age group, gender, ethnicity, marital status, education and household income), lifestyle factors (BMI, smoking and drinking statues), sleep duration and the presence of any mental disorder as covariates. By doing so, we were able to control for the effect of multimorbidity among the individuals. Two types of regression models were utilized. Binary logistic regressions were conducted when sleep quality (poor vs good) was analysed as the binary dependent variable while multinomial logistic regressions were conducted when sleep duration (≤6h vs 7-8h vs ≥9h/day) and "duration + quality" were analysed as the dependent variables with three categories. Statistical significance was set at p\<0.05 level using two-sided tests. As this study was exploratory in nature, corrections for multiple comparisons were not performed.

Results {#sec010}
=======

A total of 6,126 residents were interviewed for the SMHS 2016 study. [Table 1](#pone.0235816.t001){ref-type="table"} shows the demographic distribution of the total sample, stratified by sleep quality and sleep duration (see [S1 Table](#pone.0235816.s001){ref-type="supplementary-material"} for the distribution of physical and mental disorders, stratified by sleep quality and sleep duration).

10.1371/journal.pone.0235816.t001

###### Sociodemographic and sleep profile of population (n = 6,126).

![](pone.0235816.t001){#pone.0235816.t001g}

                                             N                      Weighted %   Sleep Quality   Sleep Duration                                                           
  ------------------------------------------ ---------------------- ------------ --------------- ---------------- ------ ------ ------ ------ ------ ------ ------ ------ -----
  Age Group (years)                          18--34                 1707         30.4            704              41.5   992    58.5   803    47.1   790    46.3   112    6.6
  35--49                                     1496                   29.6         507             34.1             979    65.9   757    50.7   690    46.2   47     3.1    
  50--64                                     1626                   26.9         580             36.0             1032   64.0   877    54.0   695    42.8   51     3.1    
  65+                                        1297                   13.1         528             41.2             755    58.8   650    50.4   556    43.1   84     6.5    
  Gender                                     Male                   3068         49.6            1087             35.8   1952   64.2   1547   50.6   1358   44.4   155    5.1
  Female                                     3058                   50.4         1232            40.6             1806   59.4   1540   50.5   1373   45.0   139    4.6    
  Ethnicity                                  Chinese                1782         75.7            592              33.5   1176   66.5   756    42.5   891    50.1   132    7.4
  Malay                                      1990                   12.5         816             41.3             1161   58.7   1220   61.6   693    35.0   69     3.5    
  Indian                                     1844                   8.7          718             39.3             1108   60.7   871    47.3   887    48.2   83     4.5    
  Others                                     510                    3.1          193             38.1             313    61.9   240    47.1   260    51.0   10     2.0    
  Marital status                             Married                3843         59.8            1348             35.4   2465   64.6   1950   50.8   1733   45.2   152    4.0
  Never married                              1544                   31.0         633             41.3             898    58.7   729    47.3   701    45.5   112    7.3    
  Divorced/ separated/widowed                739                    9.2          338             46.1             395    53.9   408    55.5   297    40.4   30     4.1    
  Education                                  Primary & below        1187         16.3            481              40.8   697    59.2   629    53.1   479    40.5   76     6.4
  Secondary                                  1648                   23.0         646             39.5             988    60.5   874    53.3   685    41.8   81     4.9    
  Post-secondary to Pre-university           1836                   31.3         731             40.1             1094   59.9   933    50.8   802    43.7   101    5.5    
  University                                 1455                   29.4         461             32.0             979    68.0   651    44.8   765    52.7   36     2.5    
  Employment                                 Employed               4055         72.0            1454             36.1   2573   63.9   2094   51.7   1828   45.1   128    3.2
  Economically inactive                      1716                   22.7         697             41.0             1002   59.0   833    48.7   748    43.7   129    7.5    
  Unemployed                                 354                    5.3          168             48.0             182    52.0   159    45.3   155    44.2   37     10.5   
  Household income (SGD)                     Below 2000             1147         14.8            503              44.2   636    55.8   590    51.7   470    41.2   81     7.1
  2000--3999                                 1331                   18.0         538             40.6             787    59.4   735    55.3   536    40.3   59     4.4    
  4000--5999                                 1113                   19.2         400             36.3             703    63.7   596    53.6   472    42.5   43     3.9    
  6000--9999                                 1003                   19.6         365             36.7             630    63.3   478    47.7   491    49.0   33     3.3    
  10000 and above                            861                    18.3         276             32.4             575    67.6   375    43.7   460    53.6   24     2.8    
  BMI (kg/m^2^)                              Underweight (\<18.5)   265          6.4             103              39.2   160    60.8   105    39.6   137    51.7   23     8.7
  Low risk (18.5--22.9)                      1372                   32.6         505             36.9             862    63.1   624    45.5   672    49.0   76     5.5    
  Moderate risk (23.0--27.4)                 2000                   39.7         716             36.1             1267   63.9   960    48.0   940    47.0   98     4.9    
  High risk (\>27.4)                         1642                   21.3         659             40.4             973    59.6   955    58.2   635    38.7   50     3.0    
  Smoking status                             Current smoker         1180         16.0            495              42.1   680    57.9   642    54.5   474    40.2   62     5.3
  Ex-smoker                                  747                    10.6         307             41.3             437    58.7   396    53.1   304    40.8   46     6.2    
  Non-smoker                                 4195                   73.3         1516            36.5             2639   63.5   2047   48.9   1952   46.6   186    4.4    
  Drinking status during the last 12-month   Non-drinker            3996         50.4            1511             38.0   2462   62.0   2126   53.2   1679   42.0   188    4.7
  \<1 episode per month                      1075                   28.1         395             37.0             672    63.0   485    45.2   534    49.7   55     5.1    
  \<5 episodes per month                     695                    14.9         269             39.0             421    61.0   303    43.7   360    51.9   31     4.5    
  ≥5 episodes per month                      349                    6.6          142             41.2             203    58.8   171    49.0   158    45.3   20     5.7    

Associations of each independent sleep variable with physical disorders {#sec011}
-----------------------------------------------------------------------

[Table 2](#pone.0235816.t002){ref-type="table"} shows the associations between chronic physical disorders and each independent sleep variable. After adjusting for sociodemographic/ lifestyle factors, all other physical disorders, any lifetime mental disorder and the other sleep measure, those who had poor sleep (vs good sleep; OR = 1.6, 95% CI 1.3--2.0) and those who slept ≤6h/day (vs 7-8h/day; OR = 1.4, 95% CI 1.1--1.7) in the past month were both significantly associated with higher odds of having a chronic pain condition. Further analysis involving the individual pain conditions revealed only migraine headaches (OR = 1.6, 95% CI 1.2--2.2, p = 0.002) to be significantly associated with short sleep while both migraine headaches (OR = 1.8, 95% CI 1.3--2.4, p\<0.001) and back problems (OR = 1.4 95% CI 1.1--1.9, p = 0.018) were significantly associated with poor sleep. Poor sleep quality was also associated with having higher odds of having any physical disorder (OR = 1.4, 95% CI 1.1--1.7).

10.1371/journal.pone.0235816.t002

###### Independent associations between sleep quality/ duration and physical health conditions[^1^](#t002fn001){ref-type="table-fn"} (n = 5,186).

![](pone.0235816.t002){#pone.0235816.t002g}

                                                                   Sleep Quality[^2^](#t002fn002){ref-type="table-fn"}   Sleep Duration[^3^](#t002fn003){ref-type="table-fn"}                                                                             
  ---------------------------------------------------------------- ----------------------------------------------------- ------------------------------------------------------ ------- --------- ------- ------- ------- ------- ------- ------- ------- -------
  Hypertension                                                     1.086                                                 0.843                                                  1.401   0.523     1.125   0.880   1.439   0.347   0.987   0.546   1.787   0.966
  Hyperlipidaemia                                                  1.131                                                 0.878                                                  1.458   0.340     0.978   0.772   1.239   0.855   1.067   0.614   1.852   0.819
  Diabetes                                                         1.173                                                 0.874                                                  1.574   0.288     0.977   0.722   1.321   0.879   1.031   0.575   1.850   0.918
  Asthma                                                           1.011                                                 0.784                                                  1.304   0.931     1.174   0.899   1.534   0.239   0.653   0.349   1.221   0.182
  Chronic pain[^a^](#t002fn005){ref-type="table-fn"}               1.582                                                 1.275                                                  1.964   \<0.001   1.372   1.098   1.715   0.005   0.771   0.432   1.373   0.377
  Cardiovascular disorders[^b^](#t002fn006){ref-type="table-fn"}   0.897                                                 0.606                                                  1.326   0.585     0.791   0.526   1.190   0.261   0.655   0.288   1.489   0.312
  Thyroid diseases                                                 1.126                                                 0.665                                                  1.906   0.658     1.244   0.728   2.125   0.424   0.734   0.227   2.374   0.605
  Ulcer[^c^](#t002fn007){ref-type="table-fn"}                      1.701                                                 0.901                                                  3.211   0.101     1.164   0.597   2.269   0.655   0.879   0.185   4.168   0.871
  Cancer                                                           1.122                                                 0.595                                                  2.117   0.722     0.809   0.424   1.542   0.519   2.318   0.748   7.180   0.145
  Any physical disorder[^4^](#t002fn004){ref-type="table-fn"}      1.393                                                 1.148                                                  1.689   0.001     1.148   0.953   1.383   0.147   0.855   0.580   1.261   0.429

^1^ Analysis controlled for sociodemographic/ lifestyle factors + all other physical disorders + any lifetime mental disorder

^2^ Analyses controlled for sleep duration

^3^ Analyses controlled for sleep quality

^4^ Analysis controlled for sociodemographic/ lifestyle factors + any mental disorder only (n = 5,242)

^a^ Comprises arthritis or rheumatism, back problems including disk or spine problems, migraine headaches

^b^ Comprises stroke or major paralysis, heart attack, coronary heart disease, angina, congestive heart failure or other heart disease

^c^ Comprises chronic inflamed bowel problems such as stomach ulcer, enteritis or colitis

Associations of each independent sleep variable with mental disorders {#sec012}
---------------------------------------------------------------------

[Table 3](#pone.0235816.t003){ref-type="table"} shows the associations between lifetime and 12-month mental disorders with each independent sleep variable. After adjusting for sociodemographic/ lifestyle factors, all other mental disorders, any physical disorder and the other sleep measure, poor (vs good) sleep quality in the past month was significantly associated with having increased odds of having MDD (lifetime: OR = 2.0, 95% CI 1.4--2.9; 12-month: OR = 3.1, 95% CI 1.8--5.4), BD (lifetime: OR = 2.8, 95% CI 1.5--5.2; 12-month: OR = 4.2, 95% CI 1.8--9.4), GAD (lifetime: OR = 2.3, 95% CI 1.2--4.4; 12-month: OR = 4.3, 95% CI 1.8--10.5), and OCD (lifetime: OR = 2.2, 95% CI 1.4--3.4; 12-month: OR = 2.4, 95% CI 1.4--3.9), while having ≤6h/day (vs 7-8h/day) sleep duration in the past month was associated with increased odds of having OCD (lifetime: OR = 1.6, 95% CI 1.0--2.5; 12-month: OR = 2.0, 95% CI 1.2--3.3). In addition, poor sleep quality was associated with having any mental disorder (lifetime: OR = 2.2, 95% CI 1.7--2.8; 12-month: OR = 3.2, 95% CI 2.3--4.3).

10.1371/journal.pone.0235816.t003

###### Independent associations between sleep quality/ duration and mental health conditions[^1^](#t003fn001){ref-type="table-fn"}.
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                                                              Sleep Quality[^2^](#t003fn002){ref-type="table-fn"}   Sleep Duration[^3^](#t003fn003){ref-type="table-fn"}                                                                                         
  ----------------------------------------------------------- ----------------------------------------------------- ------------------------------------------------------ -------- --------- --------- ------- ------- ------- ------- ------- -------- ------- -------
  Lifetime                                                    MDD                                                   2.019                                                  1.407    2.897     \<0.001   1.091   0.754   1.578   0.644   1.252   0.593    2.643   0.555
  DD                                                          3.572                                                 0.686                                                  18.606   0.131     0.542     0.169   1.742   0.304   3.055   0.282   33.142   0.358   
  BD                                                          2.765                                                 1.483                                                  5.155    0.001     1.226     0.627   2.398   0.552   1.068   0.251   4.539    0.929   
  GAD                                                         2.310                                                 1.219                                                  4.376    0.010     0.983     0.544   1.777   0.956   1.059   0.169   6.620    0.951   
  OCD                                                         2.193                                                 1.398                                                  3.439    0.001     1.598     1.009   2.530   0.046   0.754   0.203   2.801    0.673   
  AUD                                                         1.009                                                 0.646                                                  1.577    0.967     0.932     0.583   1.489   0.768   1.158   0.415   3.232    0.780   
  Any mental disorder[^4^](#t003fn004){ref-type="table-fn"}   2.170                                                 1.699                                                  2.772    \<0.001   1.292     1.002   1.666   0.048   0.987   0.525   1.855    0.968   
  12-month                                                    MDD                                                   3.128                                                  1.802    5.430     \<0.001   1.302   0.735   2.308   0.366   0.687   0.158    2.979   0.615
  DD                                                          2.292                                                 0.529                                                  9.931    0.267     0.445     0.131   1.514   0.195   \-      \-      \-       \-      
  BD                                                          4.154                                                 1.842                                                  9.367    0.001     1.529     0.700   3.341   0.286   0.107   0.010   1.170    0.067   
  GAD                                                         4.312                                                 1.767                                                  10.523   0.001     1.283     0.533   3.091   0.578   3.170   0.378   26.599   0.288   
  OCD                                                         2.365                                                 1.444                                                  3.872    0.001     1.992     1.184   3.349   0.009   1.329   0.330   5.359    0.689   
  AUD                                                         1.320                                                 0.579                                                  3.013    0.509     0.474     0.172   1.307   0.149   0.801   0.124   5.173    0.816   
  Any mental disorder[^4^](#t003fn004){ref-type="table-fn"}   3.152                                                 2.290                                                  4.339    \<0.001   1.418     1.013   1.985   0.042   0.908   0.366   2.253    0.835   

^1^ Analysis controlled for sociodemographic/ lifestyle factors + all other mental disorders + any physical disorder

^2^Analyses controlled for sleep duration

^3^Analyses controlled for sleep quality

^4^Analyses controlled for sociodemographic/ lifestyle factors + any physical disorder only (n = 5,242)

MDD: major depressive disorder; DD: dysthymic disorder; BD: bipolar disorder; GAD: generalized anxiety disorder; OCD: obsessive compulsive disorder; AUD: alcohol use disorder

Associations of the combined sleep variable with physical disorders {#sec013}
-------------------------------------------------------------------

[Table 4](#pone.0235816.t004){ref-type="table"} shows the associations between physical disorders with the combined sleep variable. '\<6h/day and poor sleep' (vs '7-8h/day and good sleep') was associated with increased odds of having a chronic pain condition (OR = 2.2, 95% CI 1.7--2.9) and any physical disorder (OR = 1.8, 95% CI 1.4--2.2). Further analysis involving the individual pain conditions revealed only migraine headaches (OR = 2.5, 95% CI 1.7--3.7, p\<0.001) and back problems (OR = 1.7 95% CI 1.2--2.5, p = 0.006) to be significantly associated with '\<6h/day and poor sleep'. Among those having 7-8h/day of sleep, poor (vs good) sleep quality was associated with increased odds of having ulcers and inflamed bowel disorder (OR = 3.1, 95% CI 1.2--8.0).

10.1371/journal.pone.0235816.t004

###### Combined associations of sleep quality + duration with physical health conditions[^1^](#t004fn001){ref-type="table-fn"} (n = 5,186).

![](pone.0235816.t004){#pone.0235816.t004g}

  Ref group: 7--8 hrs & good sleep                              OR                 95% CI   p-value             
  ------------------------------------------------------------- ------------------ -------- --------- --------- -------
  Hypertension                                                  ≤6h & good sleep   1.074    0.792     1.458     0.645
  ≥9h & good sleep                                              1.128              0.565    2.249     0.733     
  ≤6h & poor sleep                                              1.267              0.915    1.755     0.154     
  7-8h & poor sleep                                             1.028              0.680    1.556     0.895     
  ≥9h & poor sleep                                              0.736              0.266    2.041     0.556     
  Hyperlipidaemia                                               ≤6h & good sleep   0.906    0.679     1.208     0.500
  ≥9h & good sleep                                              1.192              0.649    2.191     0.571     
  ≤6h & poor sleep                                              1.152              0.840    1.580     0.379     
  7-8h & poor sleep                                             1.042              0.684    1.586     0.848     
  ≥9h & poor sleep                                              0.834              0.313    2.219     0.716     
  Diabetes                                                      ≤6h & good sleep   0.740    0.492     1.112     0.147
  ≥9h & good sleep                                              1.005              0.501    2.017     0.988     
  ≤6h & poor sleep                                              1.191              0.813    1.744     0.370     
  7-8h & poor sleep                                             0.761              0.458    1.263     0.291     
  ≥9h & poor sleep                                              0.982              0.361    2.673     0.972     
  Asthma                                                        ≤6h & good sleep   1.191    0.856     1.658     0.299
  ≥9h & good sleep                                              0.730              0.361    1.475     0.380     
  ≤6h & poor sleep                                              1.177              0.843    1.643     0.337     
  7-8h & poor sleep                                             1.050              0.693    1.591     0.817     
  ≥9h & poor sleep                                              \-                 \-       \-        \-        
  Chronic pain                                                  ≤6h & good sleep   1.118    0.831     1.506     0.461
  ≥9h & good sleep                                              0.839              0.432    1.631     0.605     
  ≤6h & poor sleep                                              2.199              1.677    2.884     \<0.001   
  7-8h & poor sleep                                             1.188              0.816    1.728     0.369     
  ≥9h & poor sleep                                              0.737              0.268    2.029     0.555     
  Cardiovascular disorder                                       ≤6h & good sleep   0.668    0.385     1.161     0.152
  ≥9h & good sleep                                              0.341              0.117    0.992     0.048     
  ≤6h & poor sleep                                              0.703              0.426    1.161     0.168     
  7-8h & poor sleep                                             0.543              0.264    1.116     0.097     
  ≥9h & poor sleep                                              1.514              0.416    5.507     0.529     
  Thyroid diseases                                              ≤6h & good sleep   1.534    0.799     2.945     0.198
  ≥9h & good sleep                                              \-                 \-       \-        \-        
  ≤6h & poor sleep                                              1.371              0.732    2.568     0.324     
  7-8h & poor sleep                                             1.657              0.740    3.711     0.219     
  ≥9h & poor sleep                                              \-                 \-       \-        \-        
  Ulcer                                                         ≤6h & good sleep   1.844    0.800     4.248     0.151
  ≥9h & good sleep                                              \-                 \-       \-        \-        
  ≤6h & poor sleep                                              2.107              0.914    4.857     0.080     
  7-8h & poor sleep                                             3.073              1.187    7.958     0.021     
  ≥9h & poor sleep                                              \-                 \-       \-        \-        
  Cancer                                                        ≤6h & good sleep   0.578    0.227     1.474     0.251
  ≥9h & good sleep                                              3.281              0.993    10.840    0.051     
  ≤6h & poor sleep                                              1.127              0.527    2.413     0.757     
  7-8h & poor sleep                                             0.992              0.323    3.045     0.988     
  ≥9h & poor sleep                                              \-                 \-       \-        \-        
  Any physical disorder[^2^](#t004fn002){ref-type="table-fn"}   ≤6h & good sleep   0.919    0.733     1.151     0.462
  ≥9h & good sleep                                              0.922              0.604    1.406     0.705     
  ≤6h & poor sleep                                              1.761              1.398    2.218     \<0.001   
  7-8h & poor sleep                                             0.999              0.735    1.357     0.993     
  ≥9h & poor sleep                                              0.686              0.292    1.612     0.387     

^1^ Analysis controlled for sociodemographic/ lifestyle factors + all other physical disorders + any lifetime mental disorder; data not presented for all due to low cell sizes; Ref group: 7--8 hrs & good sleep

^2^ Analysis controlled for sociodemographic/ lifestyle factors + any mental disorder only (n = 5,242)

Associations of the combined sleep variable with mental disorders {#sec014}
-----------------------------------------------------------------

[Table 5](#pone.0235816.t005){ref-type="table"} shows the associations between lifetime mental disorders with the combined sleep variable. Compared to '7-8h/day and good sleep', all three sleep duration groups (≤6h & 7-8h & ≥9h/day) with poor sleep in the past month were associated with higher chance of having lifetime MDD and any mental disorder. '≤6h/day and poor sleep' was also associated with having lifetime BD (OR = 3.8, 95% CI 1.3--11.6) and OCD (OR = 3.7, 95% CI 2.0--7.1).

10.1371/journal.pone.0235816.t005

###### Combined associations of sleep quality + duration with lifetime mental health conditions[^1^](#t005fn001){ref-type="table-fn"} (n = 5,242).

![](pone.0235816.t005){#pone.0235816.t005g}

  Ref group: 7--8 hrs & good sleep                            OR                 95% CI   p-value             
  ----------------------------------------------------------- ------------------ -------- --------- --------- -------
  MDD                                                         ≤6h & good sleep   1.095    0.627     1.913     0.749
  ≥9h & good sleep                                            1.157              0.463    2.888     0.755     
  ≤6h & poor sleep                                            2.204              1.343    3.617     0.002     
  7-8h & poor sleep                                           2.094              1.199    3.656     0.009     
  ≥9h & poor sleep                                            3.025              1.626    5.630     \<0.001   
  BD                                                          ≤6h & good sleep   0.623    0.223     1.741     0.367
  ≥9h & good sleep                                            \-                 \-       \-        \-        
  ≤6h & poor sleep                                            3.821              1.254    11.643    0.018     
  7-8h & poor sleep                                           1.171              0.236    5.799     0.847     
  ≥9h & poor sleep                                            \-                 \-       \-        \-        
  GAD                                                         ≤6h & good sleep   0.622    0.190     2.038     0.433
  ≥9h & good sleep                                            \-                 \-       \-        \-        
  ≤6h & poor sleep                                            2.203              0.823    5.898     0.116     
  7-8h & poor sleep                                           1.007              0.286    3.547     0.991     
  ≥9h & poor sleep                                            \-                 \-       \-        \-        
  OCD                                                         ≤6h & good sleep   1.179    0.527     2.637     0.688
  ≥9h & good sleep                                            \-                 \-       \-        \-        
  ≤6h & poor sleep                                            3.739              1.981    7.059     \<0.001   
  7-8h & poor sleep                                           1.466              0.625    3.437     0.379     
  ≥9h & poor sleep                                            \-                 \-       \-        \-        
  AUD                                                         ≤6h & good sleep   1.261    0.698     2.279     0.441
  ≥9h & good sleep                                            0.956              0.372    2.457     0.926     
  ≤6h & poor sleep                                            0.837              0.482    1.452     0.526     
  7-8h & poor sleep                                           1.539              0.826    2.868     0.175     
  ≥9h & poor sleep                                            2.435              0.864    6.867     0.092     
  Any mental disorder[^2^](#t005fn002){ref-type="table-fn"}   ≤6h & good sleep   1.044    0.734     1.486     0.810
  ≥9h & good sleep                                            0.797              0.367    1.732     0.567     
  ≤6h & poor sleep                                            2.741              2.012    3.733     \<0.001   
  7-8h & poor sleep                                           1.622              1.099    2.393     0.015     
  ≥9h & poor sleep                                            2.749              1.070    7.063     0.036     

^1^ Analyses controlled for sociodemographic/ lifestyle factors + all other lifetime mental disorders + any physical disorder; data not presented for all (including dysthymia) due to low cell sizes; 7--8 hrs & good sleep assigned as reference group.

^2^ Analysis controlled for sociodemographic/ lifestyle factors + any physical disorder only (n = 5,242)

MDD: major depressive disorder; BD: bipolar disorder; GAD: generalized anxiety disorder; OCD: obsessive compulsive disorder; AUD: alcohol use disorder

[Table 6](#pone.0235816.t006){ref-type="table"} shows the associations between 12-month mental disorders with the combined sleep variable. '≤6h/day and poor sleep' (vs '7-8h/day and good sleep') in the past month was associated with higher chance of having lifetime MDD (OR = 3.5, 95% CI 1.7--7.1), BD (OR = 4.4, 95% CI 1.4--13.6), GAD (OR = 3.8, 95% CI 1.2--11.9), OCD (OR = 4.3, 95% CI 2.3--8.3), and any mental disorder (OR = 3.9, 95% CI 2.6--5.9).

10.1371/journal.pone.0235816.t006

###### Combined associations of sleep quality + duration with 12-month mental health conditions[^1^](#t006fn001){ref-type="table-fn"} (n = 5,242).

![](pone.0235816.t006){#pone.0235816.t006g}

  Ref group: 7--8 hrs & good sleep                            OR                 95% CI   p-value             
  ----------------------------------------------------------- ------------------ -------- --------- --------- -------
  MDD                                                         ≤6h & good sleep   0.742    0.275     2.002     0.556
  ≥9h & good sleep                                            \-                 \-       \-        \-        
  ≤6h & poor sleep                                            3.512              1.746    7.062     \<0.001   
  7-8h & poor sleep                                           2.196              0.897    5.380     0.085     
  ≥9h & poor sleep                                            \-                 \-       \-        \-        
  BD                                                          ≤6h & good sleep   0.484    0.124     1.889     0.296
  ≥9h & good sleep                                            \-                 \-       \-        \-        
  ≤6h & poor sleep                                            4.402              1.421    13.632    0.010     
  7-8h & poor sleep                                           2.877              0.809    10.229    0.103     
  ≥9h & poor sleep                                            \-                 \-       \-        \-        
  GAD                                                         ≤6h & good sleep   0.307    0.079     1.197     0.089
  ≥9h & good sleep                                            \-                 \-       \-        \-        
  ≤6h & poor sleep                                            3.758              1.192    11.855    0.024     
  7-8h & poor sleep                                           1.333              0.291    6.104     0.712     
  ≥9h & poor sleep                                            \-                 \-       \-        \-        
  OCD                                                         ≤6h & good sleep   1.464    0.638     3.362     0.368
  ≥9h & good sleep                                            \-                 \-       \-        \-        
  ≤6h & poor sleep                                            4.312              2.250    8.264     \<0.001   
  7-8h & poor sleep                                           1.660              0.693    3.975     0.255     
  ≥9h & poor sleep                                            \-                 \-       \-        \-        
  AUD                                                         ≤6h & good sleep   0.429    0.098     1.883     0.262
  ≥9h & good sleep                                            \-                 \-       \-        \-        
  ≤6h & poor sleep                                            0.663              0.247    1.782     0.415     
  7-8h & poor sleep                                           1.477              0.446    4.890     0.523     
  ≥9h & poor sleep                                            \-                 \-       \-        \-        
  Any mental disorder[^2^](#t006fn002){ref-type="table-fn"}   ≤6h & good sleep   0.724    0.411     1.277     0.265
  ≥9h & good sleep                                            0.649              0.192    2.188     0.485     
  ≤6h & poor sleep                                            3.918              2.603    5.899     \<0.001   
  7-8h & poor sleep                                           1.696              0.976    2.947     0.061     
  ≥9h & poor sleep                                            2.797              0.831    9.407     0.097     

^1^ Analyses controlled for sociodemographic/ lifestyle factors + all other 12-month mental disorders + any physical disorder; data not presented for all (including dysthymia) due to low cell sizes; 7--8 hrs & good sleep assigned as reference group.

^2^ Analysis controlled for sociodemographic/ lifestyle factors + any physical disorder only (n = 5,242)

MDD: major depressive disorder; BD: bipolar disorder; GAD: generalized anxiety disorder; OCD: obsessive compulsive disorder; AUD: alcohol use disorder

Discussion {#sec015}
==========

In the current study, we assessed the associations of both sleep duration and sleep quality (independently and combined) with comorbid physical and mental disorders established using CIDI among a large pool of community-dwelling adults. By using a population cohort of healthy adults and investigating the relationship between sleep and diseases across multiple health domains in the same sample, we can circumvent challenges associated with studying clinical populations and provide new insights.

By examining sleep duration alongside with sleep quality and their relationships with health statuses from the same population, the current study may be able to provide some form of comparative evidence to determine which of these two sleep indicators may be more important for public health, based on independent associations. The associated physical comorbidities were found to be similar for poor sleep quality and short sleep duration, with only slightly higher odds ratios reported for the former. Sleep quality, but not sleep duration, was found to be associated with any physical disorder(s). However, higher number of mental comorbidities (both lifetime and 12-month) exhibited significant associations with poor sleep quality with larger effect sizes compared to those with short sleep duration. Our findings may imply that sleep disturbance may be associated more strongly with (1) psychological health, and (2) overall health compared to sleep quantity.

Other studies have reported similar findings with regard to the importance of sleep quality over sleep duration for mental health. Gadie and colleagues \[[@pone.0235816.ref016]\] found the strongest association between sleep quality and mental health but only moderate relationships with physical and cognitive health, and such relationships observed were mostly stable across the adult lifespan. Among older adults, chronic insomnia symptoms were also associated with worse mental (difference -6.9; SE = 0.4) and physical (difference -2.8; SE = 0.4) well-being, while both recurrent long and short sleep were only associated with physical (difference -3.5; SE = 0.9) well-being \[[@pone.0235816.ref017]\]. Lastly, poor sleep quality but not sleep duration was found to have significant impact on the development of both depressive symptoms and suicidal ideation among Japanese university freshmen \[[@pone.0235816.ref031]\]. Despite the fact that research has consistently found short and long sleep to be associated with adverse health outcomes \[[@pone.0235816.ref032], [@pone.0235816.ref033]\], there seems to be a lack of studies that have provided support for the stronger role of sleep duration over sleep quality in its relation with physical health as Bin proposed \[[@pone.0235816.ref009]\]. In fact, in one study that examined how onset of impaired sleep affects the risk of established cardiovascular diseases, Clark et al. \[[@pone.0235816.ref034]\] found the onset of sleep disturbances rather than short or long sleep to predict subsequent risk of hypertension and dyslipidaemia. Although our study did not establish such association(s) between sleep quality and the specific physical conditions, the study by Clarke and colleagues does demonstrate that the quality of sleep may appear to be a more important risk factor for predicting overall health and diseases compared to the quantity of sleep. In studies conducted among college students, average sleep quality was also found to be better related to health, affect balance, satisfaction with life, and feelings of tension, depression, anger, fatigue, sleepiness and confusion than average sleep quantity \[[@pone.0235816.ref008], [@pone.0235816.ref035]\].

In terms of the associations of the combined sleep variable with health statues, our findings revealed poor sleep quality and short (\<6h/day) sleep to be associated with the largest number of physical and mental disorders among the remaining five combinations when compared to good sleep quality and mid-range (7-8h/day) sleep duration. The majority of the studies that examined similar interaction effects or associations of the combined sleep variable have consistently found poor sleep quality combined with short duration to have the greatest association with hypertension \[[@pone.0235816.ref036]\], diabetes or impaired fasting glucose \[[@pone.0235816.ref037]--[@pone.0235816.ref039]\], psychological distress \[[@pone.0235816.ref040]\], coronary heart diseases risk and cardiovascular disease mortality \[[@pone.0235816.ref041]--[@pone.0235816.ref043]\] among various populations. We also found poor sleep quality to be consistently associated with lifetime mental disorders, particularly MDD, regardless of the sleep duration. Poor sleep quality in combination with short, mid-range and long sleep was also found to have robust associations with worse physical, emotional and social functioning in a general population \[[@pone.0235816.ref013]\]. This further supports that sleep quality may more strongly associated with health conditions than sleep duration.

We did not find any association between any of the sleep measures with physical conditions such as metabolic and cardiovascular diseases despite significant associations exhibited in the vast literature \[[@pone.0235816.ref032]--[@pone.0235816.ref034], [@pone.0235816.ref036], [@pone.0235816.ref038], [@pone.0235816.ref039], [@pone.0235816.ref041]--[@pone.0235816.ref043]\]. The lack of such findings in our study may be due to the confounding effects from other physical conditions and of which, only chronic pain (including arthritis or rheumatism, back problems including disk or spine problems, migraine headaches) was found to be significantly associated with both the sleep variables. Only few population-based studies have included such an extensive range of chronic diseases \[[@pone.0235816.ref015], [@pone.0235816.ref030]\]. In the study of the Korean population, only osteoarthritis and cancer (but not any metabolic or cardiovascular disorders) were found to be associated with short (\<6h/day) sleep duration (compared to 7-8h/day) \[[@pone.0235816.ref015]\]. In the Brazil population, heart disease and vascular problems (but not metabolic conditions such as hypertension and diabetes) were found to be associated with sleep duration \[[@pone.0235816.ref030]\]. Additionally, other pain disorders such as rheumatism/arthritis/arthrosis, osteoporosis and back pain/problems were similarly found to be associated with short sleep compared to mid-range sleep duration \[[@pone.0235816.ref030]\]. In terms of mental disorders in the independent associations, we found poor sleep quality to be associated with almost all mood and anxiety disorders except dysthymia. Associations between depressive and anxiety symptoms or disorders with poor sleep quality were also well-documented in other studies \[[@pone.0235816.ref006], [@pone.0235816.ref015], [@pone.0235816.ref016], [@pone.0235816.ref030], [@pone.0235816.ref044], [@pone.0235816.ref045]\]. Furthermore, we observed that these mental disorders continued to exhibit significant associations with sleep quality regardless of whether they were lifetime or 12-month disorders. We also found that except for GAD which becomes significant in terms of its relationship with the combined sleep variable when criterion was changed from lifetime to 12-month diagnoses, the other disorders remained relatively stable in their relationships with both the independent and combined sleep variables across lifetime and 12-month disorders. This further justifies the close relationship between these affective disorders and sleep.

Research has found a possible U-shaped association between sleep duration and health, where short and long sleep (compared to normal or mid-range sleep) were related to an increased risk of morbidity and mortality \[[@pone.0235816.ref016], [@pone.0235816.ref030], [@pone.0235816.ref033], [@pone.0235816.ref046], [@pone.0235816.ref047]\]. The current study, however, did not find any curvilinear trend in all our analyses as the category of \>9h/day sleep did not exhibit significant association with any disorder. Furthermore, majority of the odds ratios reported in the associations of the physical disorders with the independent sleep variable (s) were less than 1.0, suggesting that these conditions may be negatively associated with long sleep despite being insignificant. It has been postulated that poor sleep quality may be at least partly responsible for the adverse health outcomes associated with the extremes of sleep duration \[[@pone.0235816.ref009]\]. Our analyses for the health correlates of sleep duration was controlled for sleep quality and may therefore, explain the absence of significant U-shaped associations. Another possible reason could be the relatively smaller sample size among those who had \>9h/day of long sleep (weighted prevalence rate of only 6.2%), thus resulting in lower statistical power to detect any true effect. This has also led to several unreported effect sizes and estimates in the multinomial logistic regression involving associations of the various disorders with the combined sleep variable due to low cell sizes. These findings in our study pertaining to long sleep may therefore need to be interpreted with caution.

The current study used a large nationally representative, community sample of adults from a multi-ethnic population and had addressed several shortcomings of previous studies examining morbidity associated with sleep measures. However, there were still some limitations to this present study. Firstly, although we used the CIDI to establish mental diagnoses, it was not possible to include all mental disorders due to constraints of time, costs, and respondent burden. Secondly, both sleep quality and sleep duration were self-reported; such subjective opinions of participants tend to provide an estimate rather than reflect the actual sleep conditions due to recall bias. Studies have also found that self-reported sleep duration tend to overestimate objectively measured sleep \[[@pone.0235816.ref048], [@pone.0235816.ref049]\] and the extent of over-reporting increased as sleep duration decreased \[[@pone.0235816.ref050]\]. As a result, short sleepers were at a higher risk of being misclassified as normal or long sleeper, which have possibly led to an inability to detect an increased health risk among such individuals. However, misclassification can lead to bias in either direction (i.e., towards or away from the null). Lastly, causation relationships between sleep and chronic diseases cannot be inferred due to the cross-sectional design of this study. Furthermore, we have used sleep measures in the last one month as a proxy to examine their relationship with lifetime and 12-month health conditions and hence, only associations between sleep and health could be established, and we would have to rule out any impact of sleep on health outcomes which would be of greater concern in the medical research. There is a need to conduct longitudinal studies to shed more light on the directions of influence between these variables.

Conclusions {#sec016}
===========

This study examined the associations of two sleep variables--sleep duration and sleep quality (independently and combined) with chronic morbidities. Both physical and mental health domains were examined and diagnoses were collected using the validated CIDI. Our findings indicated that sleep quality may be a more important indicator for psychological and overall health compared to sleep duration. We did not observe a U-shaped relationship between sleep duration and morbidity, as only short sleep was associated with adverse health conditions. Poor sleep quality combined with short sleep was associated with the highest number of morbidities and hence, there is a need for public awareness on the relationship between sleep and health.

Supporting information {#sec017}
======================

###### Distribution of physical and mental disorders, stratified by sleep duration and sleep quality.

MDD: major depressive disorder; DD: dysthymic disorder; BD: bipolar disorder; GAD: generalized anxiety disorder; OCD: obsessive compulsive disorder; AUD: alcohol use disorder.
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Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: The background is largely and purposely limited.

These are uncited meta-analyses (sic) that -in different way- assess the relation between sleep duration and quality and health otcomes.
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Jike M et al. Long sleep duration and health outcomes: A systematic review, meta-analysis and meta-regression. Sleep Med Rev. (2018)

Li Y, Cai S, Ling Y, Mi S, Fan C, Zhong Y, Shen Q. Association between total sleep time and all cancer mortality: non-linear dose-response meta-analysis of cohort studies.
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García-Perdomo HA, Zapata-Copete J, Rojas-Cerón CA. Sleep duration and risk of all-cause mortality: a systematic review and meta-analysis. Sleep Med Rev. 2019 Feb;43:71-83. doi: 10.1016/j.smrv.2018.10.004.

Krittanawong C, Tunhasiriwet A, Wang Z, Zhang H, Farrell AM, Chirapongsathorn S, Sun T, Kitai T, Argulian E. Association between short and long sleep durations and cardiovascular outcomes: a systematic review and meta-analysis. Epidemiol Psychiatr Sci. 2019 Oct;28(5):578-588. doi: 10.1017/S2045796018000379.

Jike M, Itani O, Watanabe N, Buysse DJ, Kaneita Y. Long sleep duration and health outcomes: A systematic review, meta-analysis and meta-regression. Eur Heart J Acute Cardiovasc Care. 2019 Dec;8(8):762-770. doi: 10.1177/2048872617741733.

Itani O, Jike M, Watanabe N, Kaneita Y. Short sleep duration and health outcomes: a systematic review, meta-analysis, and meta-regression. Sleep Med Rev. 2018 Jun;39:25-36. doi: 10.1016/j.smrv.2017.06.011.

Li W, Wang D, Cao S, Yin X, Gong Y, Gan Y, Zhou Y, Lu Z. Sleep duration and risk of stroke events and stroke mortality: A systematic review and meta-analysis of prospective cohort studies. Int J Cardiol. 2016 Nov 15;223:870-876. doi: 10.1016/j.ijcard.2016.08.302.

Liu TZ, Xu C, Rota M, Cai H, Zhang C, Shi MJ, Yuan RX, Weng H, Meng XY, Kwong JS, Sun X. Sleep duration and risk of all-cause mortality: A flexible, non-linear, meta-regression of 40 prospective cohort studies. Sleep Med Rev. 2017 Apr;32:28-36. doi: 10.1016/j.smrv.2016.02.005.

Yang X, Chen H, Li S, Pan L, Jia C. Association of Sleep Duration with the Morbidity and Mortality of Coronary Artery Disease: A Meta-analysis of Prospective Studies. Heart Lung Circ. 2015 Dec;24(12):1180-90. doi: 10.1016/j.hlc.2015.08.005.

Irwin MR, Olmstead R, Carroll JE. Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation. Biol Psychiatry. 2016 Jul 1;80(1):40-52. doi: 10.1016/j.biopsych.2015.05.014.

Li Y, Zhang X, Winkelman JW, Redline S, Hu FB, Stampfer M, Ma J, Gao X. Association between insomnia symptoms and mortality: a prospective study of U.S. men. Circulation. 2014 Feb 18;129(7):737-46. doi: 10.1161/CIRCULATIONAHA.113.004500. Epub 2013 Nov 13.

Sofi F, Cesari F, Casini A, Macchi C, Abbate R, Gensini GF. Insomnia and risk of cardiovascular disease: a meta-analysis. Eur J Prev Cardiol. 2014 Jan;21(1):57-64. doi: 10.1177/2047487312460020. Epub 2012 Aug 31. Review.

Reviewer \#2: This is a large cross sectional study on sleep and mental health. The theme is interesting and may attract readers.

Not only sleep duration, but sleep quality may be important.

I have some minor comments.

1\) Please add numbers in tables 2-6, otherwise readers can not tell the numbers are large enough for the analysis.

2\) Global scores of PSQI are calculated from scores including sleep duration. You are analyzing sleep quality (defined from PSQI global score) and sleep duration (a part of PSQI). Please discuss this with some reasoning.

Reviewer \#3: Comments to the Authors

This paper examined the independent and combined associations of sleep duration and sleep quality with lifetime or 12-month experience of common physical and mental disorders. Sleep duration and sleep quality were assessed using the Pittsburgh Sleep Quality Index while lifetime or 12-month medical and psychiatric diagnoses were established using the WHO Composite International Diagnostic Interview 3.0. Results from this multi-ethnic population-based cross-sectional survey showed that across both 12-month and lifetime diagnoses, sleep duration and sleep quality were independently associated with chronic pain, obsessive compulsive disorder and any mental disorder while sleep quality was additionally associated with major depressive disorder, bipolar disorder, generalized anxiety disorder and any physical disorder. Poor sleep combined with short sleep (\< 6hrs/day vs 7-8hrs/day) was associated with the highest number of comorbidities among other sleep combinations. Authors conclude that their findings suggest sleep quality to be a more important indicator for psychological and overall health compared to sleep duration.

I think the paper is detailed, thoughtfully written, well presented and has a well justified underlying rationale. The various sections of the paper from the introduction, methods, statistical analysis, results and discussions were well articulated, easy to read and understand. In general, the results and conclusion appear quite straightforward. However, various clarifications and/or issues that need to be addressed are reported below.

In the introduction, authors state "Secondly, Bin also highlighted that sleep duration and

quality have been conceptualized so distinctly that many have failed to recognise that they are measures of the same underlying phenomenon \[3\]"....authors should also add the fact that sleep duration and quality measure different constructs.

In the introduction, authors state "...................association of the two sleep measures with both physical and mental health \[4-8\], mental health was mainly evaluated only at symptomatic level." Please authors should clarify what they mean by "symptomatic level"

Can the authors rephrase the use of the word "Aforementioned" in the sentence "Aforementioned, sleep characteristics in general populations have been studied;" Rephrase to something like "As noted previously"

The use of the word "outcome" to refer to sleep measures is confusing. Sleep measures suffices especially since these measures are your independent variables

For mental disorders authors note that "We examined both the lifetime and 12-month prevalence to explore possible........" Can the authors clarify how they assessed for and determined lifetime or 12-month prevalence?

Statistical analysis

Authors state that "For independent associations of each sleep variable with the various health conditions, sleep quality (poor vs good) and sleep duration (\<6h vs 7-8h vs \>9h/day) were entered as dependent variables in separate logistic regressions with the other sleep variable being controlled and entered as independent variable." This statement needs to be clarified. Other sleep variables were being assessed as independent predictors of sleep quality and sleep duration. Otherwise, the model cannot have sleep measures as dependent variables when the examination is between the sleep variables (as independent) and health conditions (as outcome or dependent variable).

"For the combined sleep variable, a single 'sleep duration & sleep quality' status with six levels (= sleep, 7- 6h & good 8h/day & good sleep; i.e., reference category; 7-8h/day & =9h & good sleep, =6h & poor sleep, poor sleep, and ) was entered as dependent variable in the multinomial =9h & poor sleep logistic regressions".

For the above statement, please also clarify what you did by entering your sleep measures or variables as dependent variables.

Authors state, "The use of CAPIs eliminated the chance of a random missing data, except refused or "Not applicable" responses which were minimal". Minimal is a relative word. Can the authors please clarify what they mean by minimal. For example, how many responses were listed as "Not Applicable (NA)" and was there any sensitivity analyses done that led to the determination of the effect of the NAs?

Authors state, "A complete case analysis was therefore adopted in the current study. Statistical significance was set at p\<0.05 level using two-sided tests." I think it is important to correct for multiple comparisons in order to control for type I error, given the number of statistical analyses performed using the same dataset and variables. Given that the main aim of this study is to investigate the relationship between the independent and combined associations of sleep duration and sleep quality with lifetime or 12-month experience of common physical and mental disorders, you can argue that you only need to correct for your p-values considering the analyses with physical (9 outcomes) and mental disorders (6 outcomes) (p=0.0033 i.e., 0.05/15 analyses). Otherwise, with 12 months and lifetime outcomes separately accounted for, then your family wise error (alpha FWE) would need to be further controlled for.

Table S1 and Table 1 should be configured into 1 table. The whole population should be described by stratified by sleep duration and sleep quality.

Can the authors define what "Any physical disorder" and "Any mental disorder" means?

Table 3 & 5: can the authors please spell out the acronyms on the table in a footnote

Discussion

Can the authors be more explicit when they state ".....some of the challenges associated with studying clinical populations have been circumvented thus providing new insights." What challenges? I only see author refer to one in the next paragraph. Are there others?

Authors discuss the limitations of the study however they fail to discuss the possible implications on their results. For example, both sleep quality and sleep duration were self-reported, how would these have led to possible misclassifications and possibly affect the effect estimate? Will it drive it towards or away from the null?
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Academic Editor
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Dear editor,

Thank you for your time in reviewing this manuscript. We would also like to thank the reviewer for their constructive comments and I have addressed their comments point-by-point below. We have ensured that our manuscript meets PLOS ONE\'s style requirements, including those for file naming and updated our Data Availability statement in the cover letter.

Reviewer \#1: The background is largely and purposely limited.

These are uncited meta-analyses (sic) that -in different way- assess the relation between sleep duration and quality and health outcomes.

da Silva AA, de Mello RG, Schaan CW, Fuchs FD, Redline S, Fuchs SC. Sleep duration and mortality in the elderly: a systematic review with meta-analysis. BMJ Open. 2016 Feb 17;6(2):e008119. doi: 10.1136/bmjopen-2015-008119.

Gallicchio L, Kalesan B. Sleep duration and mortality: a systematic review and meta-analysis. J Sleep Res. 2009 Jun;18(2):148-58. doi: 10.1111/j.1365-2869.2008.00732.x.

Shen X, Wu Y, Zhang D. Nighttime sleep duration, 24-hour sleep duration and risk of all-cause mortality among adults: a meta-analysis of prospective cohort studies. Sci Rep. 2016 Feb 22;6:21480. doi: 10.1038/srep21480.

Kawada T1. Total sleep time and all cancer mortality: a meta-analysis. Sleep Med. 2020 Apr;68:96. doi: 10.1016/j.sleep.2019.12.029. Epub 2020 Jan 10.

Ge L1, Guyatt G2, Tian J3, Pan B4, Chang Y2, Chen Y4, Li H4, Zhang J4, Li Y4, Ling J3, Yang K5. Insomnia and risk of mortality from all-cause, cardiovascular disease, and cancer: Systematic review and meta-analysis of prospective cohort studies. Sleep Med Rev. 2019 Dec;48:101215. doi: 10.1016/j.smrv.2019.101215.

Kwok CS1, Kontopantelis E2, Kuligowski G3, Gray M3, Muhyaldeen A4, Gale CP5, Peat GM6, Cleator J7, Chew-Graham C6, Loke YK8, Mamas MA1. Self-Reported Sleep Duration and Quality and Cardiovascular Disease and Mortality: A Dose-Response Meta-Analysis. J Am Heart Assoc. 2018 Aug 7;7(15):e008552. doi: 10.1161/JAHA.118.008552.

Yin J et al. J Relationship of Sleep Duration With All-Cause Mortality and Cardiovascular Events: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies. Am Heart Assoc. (2017)

Jike M et al. Long sleep duration and health outcomes: A systematic review, meta-analysis and meta-regression. Sleep Med Rev. (2018)

Li Y, Cai S, Ling Y, Mi S, Fan C, Zhong Y, Shen Q. Association between total sleep time and all cancer mortality: non-linear dose-response meta-analysis of cohort studies.

Ma QQ, Yao Q, Lin L, Chen GC, Yu JB. Sleep duration and total cancer mortality: a meta-analysis of prospective studies. Sleep Med. 2016 Nov - Dec;27-28:39-44. doi: 10.1016/j.sleep.2016.06.036.

Stone CR, Haig TR, Fiest KM, McNeil J, Brenner DR, Friedenreich CM. The association between sleep duration and cancer-specific mortality: a systematic review and meta-analysis. Sleep Med. 2019 Aug;60:211-218. doi: 10.1016/j.sleep.2019.03.026.

Lovato N, Lack L. Insomnia and mortality: A meta-analysis. Cancer Causes Control. 2019 May;30(5):501-525. doi: 10.1007/s10552-019-01156-4. Epub 2019 Mar 22.

García-Perdomo HA, Zapata-Copete J, Rojas-Cerón CA. Sleep duration and risk of all-cause mortality: a systematic review and meta-analysis. Sleep Med Rev. 2019 Feb;43:71-83. doi: 10.1016/j.smrv.2018.10.004.

Krittanawong C, Tunhasiriwet A, Wang Z, Zhang H, Farrell AM, Chirapongsathorn S, Sun T, Kitai T, Argulian E. Association between short and long sleep durations and cardiovascular outcomes: a systematic review and meta-analysis. Epidemiol Psychiatr Sci. 2019 Oct;28(5):578-588. doi: 10.1017/S2045796018000379.

Jike M, Itani O, Watanabe N, Buysse DJ, Kaneita Y. Long sleep duration and health outcomes: A systematic review, meta-analysis and meta-regression. Eur Heart J Acute Cardiovasc Care. 2019 Dec;8(8):762-770. doi: 10.1177/2048872617741733.

Itani O, Jike M, Watanabe N, Kaneita Y. Short sleep duration and health outcomes: a systematic review, meta-analysis, and meta-regression. Sleep Med Rev. 2018 Jun;39:25-36. doi: 10.1016/j.smrv.2017.06.011.

Li W, Wang D, Cao S, Yin X, Gong Y, Gan Y, Zhou Y, Lu Z. Sleep duration and risk of stroke events and stroke mortality: A systematic review and meta-analysis of prospective cohort studies. Int J Cardiol. 2016 Nov 15;223:870-876. doi: 10.1016/j.ijcard.2016.08.302.

Liu TZ, Xu C, Rota M, Cai H, Zhang C, Shi MJ, Yuan RX, Weng H, Meng XY, Kwong JS, Sun X. Sleep duration and risk of all-cause mortality: A flexible, non-linear, meta-regression of 40 prospective cohort studies. Sleep Med Rev. 2017 Apr;32:28-36. doi: 10.1016/j.smrv.2016.02.005.

Yang X, Chen H, Li S, Pan L, Jia C. Association of Sleep Duration with the Morbidity and Mortality of Coronary Artery Disease: A Meta-analysis of Prospective Studies. Heart Lung Circ. 2015 Dec;24(12):1180-90. doi: 10.1016/j.hlc.2015.08.005.

Irwin MR, Olmstead R, Carroll JE. Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation. Biol Psychiatry. 2016 Jul 1;80(1):40-52. doi: 10.1016/j.biopsych.2015.05.014.

Li Y, Zhang X, Winkelman JW, Redline S, Hu FB, Stampfer M, Ma J, Gao X. Association between insomnia symptoms and mortality: a prospective study of U.S. men. Circulation. 2014 Feb 18;129(7):737-46. doi: 10.1161/CIRCULATIONAHA.113.004500. Epub 2013 Nov 13.

Sofi F, Cesari F, Casini A, Macchi C, Abbate R, Gensini GF. Insomnia and risk of cardiovascular disease: a meta-analysis. Eur J Prev Cardiol. 2014 Jan;21(1):57-64. doi: 10.1177/2047487312460020. Epub 2012 Aug 31. Review.

We thank the reviewer for the references provided. Majority of the above meta-analyses focused on the relationship between sleep duration and cardiovascular diseases and cancers, as well as with all-cause mortality. We have cited those conducted among cohort studies to complement our introduction. We have also cited those that looked at the relationship between insomnia symptoms and health outcomes in a separate line.

Reviewer \#2: This is a large cross sectional study on sleep and mental health. The theme is interesting and may attract readers. Not only sleep duration, but sleep quality may be important. I have some minor comments.

1\) Please add numbers in tables 2-6, otherwise readers cannot tell the numbers are large enough for the analysis.

We have added the numbers as requested.

2\) Global scores of PSQI are calculated from scores including sleep duration. You are analyzing sleep quality (defined from PSQI global score) and sleep duration (a part of PSQI). Please discuss this with some reasoning.

We have discussed this in our methodology under the section of 'sleep measures'.

Reviewer \#3: This paper examined the independent and combined associations of sleep duration and sleep quality with lifetime or 12-month experience of common physical and mental disorders. Sleep duration and sleep quality were assessed using the Pittsburgh Sleep Quality Index while lifetime or 12-month medical and psychiatric diagnoses were established using the WHO Composite International Diagnostic Interview 3.0. Results from this multi-ethnic population-based cross-sectional survey showed that across both 12-month and lifetime diagnoses, sleep duration and sleep quality were independently associated with chronic pain, obsessive compulsive disorder and any mental disorder while sleep quality was additionally associated with major depressive disorder, bipolar disorder, generalized anxiety disorder and any physical disorder. Poor sleep combined with short sleep (\< 6hrs/day vs 7-8hrs/day) was associated with the highest number of comorbidities among other sleep combinations. Authors conclude that their findings suggest sleep quality to be a more important indicator for psychological and overall health compared to sleep duration.

I think the paper is detailed, thoughtfully written, well presented and has a well justified underlying rationale. The various sections of the paper from the introduction, methods, statistical analysis, results and discussions were well articulated, easy to read and understand. In general, the results and conclusion appear quite straightforward. However, various clarifications and/or issues that need to be addressed are reported below.

In the introduction, authors state "Secondly, Bin also highlighted that sleep duration and

quality have been conceptualized so distinctly that many have failed to recognise that they are measures of the same underlying phenomenon \[3\]"....authors should also add the fact that sleep duration and quality measure different constructs.

We have included the above suggestion and highlighted qualitative difference between the two sleep constructs in the introduction.

In the introduction, authors state "...................association of the two sleep measures with both physical and mental health \[4-8\], mental health was mainly evaluated only at symptomatic level." Please authors should clarify what they mean by "symptomatic level"

We have provided additional information to clarify what we meant by "symptomatic level" in the introduction.

Can the authors rephrase the use of the word "Aforementioned" in the sentence "Aforementioned, sleep characteristics in general populations have been studied;" Rephrase to something like "As noted previously"

We have rephrased the word as suggested.

The use of the word "outcome" to refer to sleep measures is confusing. Sleep measures suffices especially since these measures are your independent variables

We have made the necessary changes throughout the manuscript.

For mental disorders authors note that "We examined both the lifetime and 12-month prevalence to explore possible........" Can the authors clarify how they assessed for and determined lifetime or 12-month prevalence?

We have included the further clarification in our methodology under "mental disorders" section.

Statistical analysis

Authors state that "For independent associations of each sleep variable with the various health conditions, sleep quality (poor vs good) and sleep duration (\<6h vs 7-8h vs \>9h/day) were entered as dependent variables in separate logistic regressions with the other sleep variable being controlled and entered as independent variable." This statement needs to be clarified. Other sleep variables were being assessed as independent predictors of sleep quality and sleep duration. Otherwise, the model cannot have sleep measures as dependent variables when the examination is between the sleep variables (as independent) and health conditions (as outcome or dependent variable).

"For the combined sleep variable, a single 'sleep duration & sleep quality' status with six levels (= sleep, 7- 6h & good 8h/day & good sleep; i.e., reference category; 7-8h/day & =9h & good sleep, =6h & poor sleep, poor sleep, and ) was entered as dependent variable in the multinomial =9h & poor sleep logistic regressions".

For the above statement, please also clarify what you did by entering your sleep measures or variables as dependent variables.

We will address all points above in the following. We will like to clarify that the current study is in fact exploring the association between sleep variables and health conditions, but not sleep variables as predictors of health outcomes or vice versa. The current study is cross-sectional in design and we are therefore unable to establish any casual relationships between sleep and health variables. We had cited these as our limitations. As such, we have included the sleep variable of interest as the dependent and entered all physical disorders + the other sleep variable as independent variables in a single regression model such that for example, the reported odds ratio and CI reflects the relationship of each specific disorder (e.g., hypertension) with sleep quality while controlling for all other physical disorders, any mental disorder and sleep duration. This will also allow us to address problems of comorbidities among participants. We have amended the text and provided an example in our statistical analysis to better clarify this.

Such statistical method where sleep variable is entered as the dependent variable has been used by other population-based cross-sectional studies examining the relationship between sleep measures and health-related conditions (see Ref 13, 14 and 17).

Authors state, "The use of CAPIs eliminated the chance of a random missing data, except refused or "Not applicable" responses which were minimal". Minimal is a relative word. Can the authors please clarify what they mean by minimal. For example, how many responses were listed as "Not Applicable (NA)" and was there any sensitivity analyses done that led to the determination of the effect of the NAs?

We have removed the above statement as we deemed it to be inappropriate now. We did not conduct any sensitivity analysis as non-responses appeared to come from various variables such as sociodemographic, health conditions, and sleep variables.

Authors state, "A complete case analysis was therefore adopted in the current study. Statistical significance was set at p\<0.05 level using two-sided tests." I think it is important to correct for multiple comparisons in order to control for type I error, given the number of statistical analyses performed using the same dataset and variables. Given that the main aim of this study is to investigate the relationship between the independent and combined associations of sleep duration and sleep quality with lifetime or 12-month experience of common physical and mental disorders, you can argue that you only need to correct for your p-values considering the analyses with physical (9 outcomes) and mental disorders (6 outcomes) (p=0.0033 i.e., 0.05/15 analyses). Otherwise, with 12 months and lifetime outcomes separately accounted for, then your family wise error (alpha FWE) would need to be further controlled for.

As noted previously, we have entered all listed physical disorders as independent variables in one model and all mental disorders as independent variables in a separate regression model to look at the association of each specific disorder with the sleep variable of interest, which was entered as dependent variable. Therefore, only 3 main testings or regression models (for physical disorders, 12-month mental disorders and lifetime mental disorders) were run for each of the sleep dependent variables. For example, Table 4, 5 and 6 represent findings from the three models run for the "quality + duration" sleep variable. We have provided further clarity on this in our statistical analyses. We have also stated that the study is exploratory in nature, and thus did not correct for multiple comparisons. Moreover, the idea of correcting of multiple comparisons is still debatable in the literature (O'Keefe, 2003).

O\'Keefe, D.J. (2003), Colloquy: Should Familywise Alpha Be Adjusted?. Human Communication Research, 29: 431-447. doi:10.1111/j.1468-2958.2003.tb00846.x.

Table S1 and Table 1 should be configured into 1 table. The whole population should be described by stratified by sleep duration and sleep quality.

We are unable to combine S1 into Table 1 as S1 does not include the entire population but only those with the specific physical and mental disorders. We have, however, stratified the whole population by sleep duration and sleep quality in Table 1 as suggested.

Can the authors define what "Any physical disorder" and "Any mental disorder" means?

We have defined them in the methodology.

Table 3 & 5: can the authors please spell out the acronyms on the table in a footnote

We have spelt out the acronyms as suggested.

Discussion

Can the authors be more explicit when they state ".....some of the challenges associated with studying clinical populations have been circumvented thus providing new insights." What challenges? I only see author refer to one in the next paragraph. Are there others?

The two advantages would be (1) providing comparative data to determine whether sleep quality or sleep duration is more related to public health, and (2) be able to link each of these two sleep components to both physical and mental disorders. As highlighted in the introduction, Bin (2016) addressed two major concerns with regards to the literature looking at the relationship between sleep and health, and hence our study hope to address these concerns. These are implied in the same paragraph.

Authors discuss the limitations of the study however they fail to discuss the possible implications on their results. For example, both sleep quality and sleep duration were self-reported, how would these have led to possible misclassifications and possibly affect the effect estimate? Will it drive it towards or away from the null?

We have discussed the how self-reported sleep indicators would possibly lead to misclassification and affect effect estimate. However, we are unable to confirm the direction of change.

We hope that we have adequately addressed the reviewer's comments. Thank you for allowing us to resubmit this revised manuscript for further consideration.

Sincerely,

Esmond Seow

Research Division

Institute of Mental Health, Singapore
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